Validation of small molecules preventing TDP-43 aggregation as a therapeutic for Amyotrophic Lateral Sclerosis TDP-43 is a protein that behaves abnormally in the motor neurons of 97 per cent of people with ALS. Grant type Capacity building grants Area of Research Neurodegeneration Competition ALS Canada - Brain Canada Trainee Program 2019 Province Ontario Start Date 2019
